RGEN FY 2020 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$366M+35.5% YoY

Gross Profit

$194M53.1% margin

Operating Income

$81M22.2% margin

Net Income

$60M16.4% margin

EPS (Diluted)

$1.11

Cash Flow

Operating Cash Flow

$63M

Free Cash Flow

$36M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$374M

Stockholders' Equity

$1.5B

Cash & Equivalents

$717M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$366M	$270M	+35.5%
Gross Profit	$194M	$138M	+40.6%
Operating Income	$81M	$40M	+102.8%
Net Income	$60M	$21M	+179.9%